Gennex Laboratories Limited (GENNEX) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE509C01026
Key metrics
- Market Cap
- ₹315 Cr
- P/E Ratio
- 17.5
- EPS
- 0.74
- Book Value
- 9.58
- P/B Ratio
- 1.35
- ROE
- 9.01%
- ROCE
- 6.34%
- Debt / Equity
- 0.34
- Net Margin
- 12.14%
- Revenue Growth
- 25.26%
- Profit Growth
- 15.75%
- Dividend Yield
- —
- 52W High
- ₹17.25
- 52W Low
- ₹7.05
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Gennex Laboratories Limited
Gennex Laboratories Limited manufactures and sells bulk drugs, intermediates, and biotech products. The company offers Guaifenesin, an expectorant used as a mucolyte; Methocarbamol for skeletal muscle relaxant; Fexofenadine Hcl for treating antihistamines; Phenazopyridine Hcl for the treatment of urinary tract analgesic; Fluconazole for antifungals; Melitracen Hcl for treating tricyclic antidepressant; Sertraline Hcl, a selective serotonin reuptake inhibitor; Chlorphenesin and Mephenesin for muscle relaxant; and Allopurinol, a xanthine oxidase inhibitor. It has operations in India, Algeria, Bangladesh, Barzil, Bolivia, Colombia, the Czech Republic, Egypt, El Salvador, Germany, Guatemala City, Mexico, Peru, Spain, Turkey, Thailand, the United Arab Emirates, and Vietnam. Gennex Laboratories Limited was formerly known as Prudential Pharmaceuticals Limited and changed its name to Gennex Laboratories Limited in September 2007. Gennex Laboratories Limited was incorporated in 1985 and is based in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Promoter Holding
- 36.48%
The full Gennex Laboratories Limited analysis
Create a free account to open the complete GENNEX deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.